Delivery Order SPE2DB22D1106-SPE2DB25FFBG5
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,822.55. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packaging) under a firm fixed price contract valued at $2,466.80. This delivery order, which was not set-aside, is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction for pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a $3,362.37 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units). This firm fixed-price contract, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The antibiotic pharmaceutical product supports federal medical procurement requirements for military and...
- This delivery order, awarded August 1, 2025, by the Medical Supply Chain under the Defense Logistics Agency, procures Ciprofloxacin HCL 500 mg tablets (100-count) from AmerisourceBergen Drug Corp with a ceiling value of $1,476.79 and firm fixed pricing. The order is scheduled for completion by August 4, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,864.20 on August 1, 2025, for the supply of Cipro 500 mg tablets in quantities of 100. This competitive award, executed under firm fixed-price terms with no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cipro 500 mg tablets (100-count units) with a ceiling value of $1,175.85. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside procurement issued to the prime contractor at its Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,877.16 by the Defense Logistics Agency Medical Supply Chain on July 30, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The antibiotic pharmaceutical delivery supports...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for ciprofloxacin hydrochloride 500 mg tablets (100 count) with a ceiling value of $1,031.40. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a single...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,196,509 units of Ciprofloxacin HCL 250 mg tablets. The $2,661.97 order is to be completed by December 29, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and distribution services in support of military...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBG5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ciprofloxacin HCL 250 mg tablets (100-count units) with a ceiling value of $1,069.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This award falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition, with this antibiotic supply supporting critical military medical readiness needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/4/25 |